Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) — Financial Flexibility Index
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) has a Financial Flexibility Index of 0.68x as of September 2025. Free cash flow of CN¥110.89 Million (operating CF CN¥88.11 Million minus capex CN¥22.77 Million) represents 1% of total liabilities (CN¥161.98 Million). Check Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (300357) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Financial Flexibility Index (2009–2024)
Historical Financial Flexibility Index trend for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd across 16 annual periods. See 300357 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd (2009–2024)
Year-by-year free cash flow to debt coverage for Zhejiang Wolwo Bio-Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Zhejiang Wolwo Bio-Pharmaceutical Co Ltd stock valuation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.52x | CN¥380.41 Million | CN¥262.44 Million | CN¥250.30 Million | ▼ -34.3% |
| 2023 | 2.31x | CN¥597.48 Million | CN¥388.32 Million | CN¥258.46 Million | ▼ -28.1% |
| 2022 | 3.22x | CN¥549.02 Million | CN¥360.28 Million | CN¥170.76 Million | ▼ -9.8% |
| 2021 | 3.57x | CN¥482.73 Million | CN¥360.58 Million | CN¥135.36 Million | ▼ -16.3% |
| 2020 | 4.26x | CN¥326.38 Million | CN¥256.22 Million | CN¥76.61 Million | ▼ -2.4% |
| 2019 | 4.36x | CN¥332.75 Million | CN¥232.93 Million | CN¥76.25 Million | ▲ +3.2% |
| 2018 | 4.23x | CN¥264.20 Million | CN¥206.45 Million | CN¥62.47 Million | ▲ +2.6% |
| 2017 | 4.12x | CN¥193.86 Million | CN¥159.13 Million | CN¥47.05 Million | ▲ +7.3% |
| 2016 | 3.84x | CN¥158.70 Million | CN¥122.77 Million | CN¥41.32 Million | ▼ -25.0% |
| 2015 | 5.12x | CN¥146.33 Million | CN¥114.82 Million | CN¥28.57 Million | ▼ -14.5% |
| 2014 | 5.99x | CN¥106.37 Million | CN¥83.70 Million | CN¥17.75 Million | ▼ -4.9% |
| 2013 | 6.30x | CN¥75.83 Million | CN¥58.30 Million | CN¥12.04 Million | ▲ +26.7% |
| 2012 | 4.97x | CN¥48.41 Million | CN¥41.17 Million | CN¥9.73 Million | ▲ +320.8% |
| 2011 | 1.18x | CN¥23.14 Million | CN¥19.15 Million | CN¥19.58 Million | ▼ -5.4% |
| 2010 | 1.25x | CN¥25.10 Million | CN¥14.54 Million | CN¥20.08 Million | ▼ -65.2% |
| 2009 | 3.59x | CN¥34.11 Million | CN¥12.63 Million | CN¥9.49 Million | — |